<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33923808</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>12</Day></DateCompleted><DateRevised><Year>2021</Year><Month>05</Month><Day>12</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>8</Issue><PubDate><Year>2021</Year><Month>Apr</Month><Day>16</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>A Metal-Free, Disulfide Oxidized Form of Superoxide Dismutase 1 as a Primary Misfolded Species with Prion-Like Properties in the Extracellular Environments Surrounding Motor Neuron-Like Cells.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">4155</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms22084155</ELocationID><Abstract><AbstractText>Superoxide dismutase 1 (SOD1) is a metalloenzyme with high structural stability, but a lack of Cu and Zn ions decreases its stability and enhances the likelihood of misfolding, which is a pathological hallmark of amyotrophic lateral sclerosis (ALS). A growing body of evidence has demonstrated that misfolded SOD1 has prion-like properties such as transmissibility between cells and intracellular propagation of misfolding of natively folded SOD1. Recently, we found that SOD1 is misfolded in the cerebrospinal fluid of sporadic ALS patients, providing a route by which misfolded SOD1 spreads via the extracellular environment of the central nervous system. Unlike intracellular misfolded SOD1, it is unknown which extracellular misfolded species is most relevant to prion-like properties. Here, we determined a conformational feature of extracellular misfolded SOD1 that is linked to prion-like properties. Using culture media from motor neuron-like cells, NSC-34, extracellular misfolded wild-type, and four ALS-causing SOD1 mutants were characterized as a metal-free, disulfide oxidized form of SOD1 (apo-SOD1<sup>S-S</sup>). Extracellular misfolded apo-SOD1<sup>S-S</sup> exhibited cell-to-cell transmission from the culture medium to recipient cells as well as intracellular propagation of SOD1 misfolding in recipient cells. Furthermore, culture medium containing misfolded apo-SOD1<sup>S-S</sup> exerted cytotoxicity to motor neuron-like cells, which was blocked by removal of misfolded apo-SOD1<sup>S-S</sup> from the medium. We conclude that misfolded apo-SOD1<sup>S-S</sup> is a primary extracellular species that is linked to prion-like properties.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Takashima</LastName><ForeName>Chika</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Laboratory of Clinical Medicine, School of Pharmacy, Nihon University, 7-7-1 Narashinodai, Funabashi, Chiba 274-8555, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kosuge</LastName><ForeName>Yasuhiro</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-7513-5132</Identifier><AffiliationInfo><Affiliation>Laboratory of Pharmacology, School of Pharmacy, Nihon University, 7-7-1 Narashinodai, Funabashi, Chiba 274-8555, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Inoue</LastName><ForeName>Masahisa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Laboratory of Structure and Functional Research, Faculty of Pharmaceutical Science, Tokushima Bunri University, 180 Nishihamaboji, Yamashiro, Tokushima 770-8514, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ono</LastName><ForeName>Shin-Ichi</ForeName><Initials>SI</Initials><AffiliationInfo><Affiliation>Laboratory of Clinical Medicine, School of Pharmacy, Nihon University, 7-7-1 Narashinodai, Funabashi, Chiba 274-8555, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Neurology, Akiru Municipal Medical Center, 78-1 Hikida, Akiruno, Tokyo 197-0834, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tokuda</LastName><ForeName>Eiichi</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-7690-3025</Identifier><AffiliationInfo><Affiliation>Laboratory of Clinical Medicine, School of Pharmacy, Nihon University, 7-7-1 Narashinodai, Funabashi, Chiba 274-8555, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>17K15077</GrantID><Agency>the Japan Society for the Promotion of Science</Agency><Country/></Grant><Grant><GrantID>2019</GrantID><Agency>the Pharmacological Foundation, Tokyo</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>04</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017077">Culture Media, Conditioned</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="C000606291">Sod1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017077" MajorTopicYN="N">Culture Media, Conditioned</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005110" MajorTopicYN="N">Extracellular Space</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017510" MajorTopicYN="Y">Protein Folding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">extracellular environment</Keyword><Keyword MajorTopicYN="N">prion-like property</Keyword><Keyword MajorTopicYN="N">protein misfolding</Keyword><Keyword MajorTopicYN="N">superoxide dismutase 1</Keyword></KeywordList><CoiStatement>The authors declare that they have no financial conflicts of interest related to this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>3</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>4</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>4</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>30</Day><Hour>1</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>5</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33923808</ArticleId><ArticleId IdType="pmc">PMC8074096</ArticleId><ArticleId IdType="doi">10.3390/ijms22084155</ArticleId><ArticleId IdType="pii">ijms22084155</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brown R.H., Al-Chalabi A. Amyotrophic Lateral Sclerosis. N. Engl. J. Med. 2017;377:162&#x2013;172. doi: 10.1056/NEJMra1603471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Spires-Jones T.L., Attems J., Thal D.R. Interactions of pathological proteins in neurodegenerative diseases. Acta Neuropathol. 2017;134:187&#x2013;205. doi: 10.1007/s00401-017-1709-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1709-7</ArticleId><ArticleId IdType="pmc">PMC5508034</ArticleId><ArticleId IdType="pubmed">28401333</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravits J., Paul P., Jorg C. Focality of upper and lower motor neuron degeneration at the clinical onset of ALS. Neurology. 2007;68:1571&#x2013;1575. doi: 10.1212/01.wnl.0000260965.20021.47.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000260965.20021.47</ArticleId><ArticleId IdType="pubmed">17485643</ArticleId></ArticleIdList></Reference><Reference><Citation>Vallabh S.M., Minikel E.V., Schreiber S.L., Lander E.S. Towards a treatment for genetic prion disease: Trials and biomarkers. Lancet Neurol. 2020;19:361&#x2013;368. doi: 10.1016/S1474-4422(19)30403-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(19)30403-X</ArticleId><ArticleId IdType="pubmed">32199098</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O&#x2019;Regan J.P., Deng H.X., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59&#x2013;62. doi: 10.1038/362059a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;nch C., O&#x2019;Brien J., Bertolotti A. Prion-like propagation of mutant superoxide dismutase-1 misfolding in neuronal cells. Proc. Natl. Acad. Sci. USA. 2011;108:3548&#x2013;3553. doi: 10.1073/pnas.1017275108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1017275108</ArticleId><ArticleId IdType="pmc">PMC3048161</ArticleId><ArticleId IdType="pubmed">21321227</ArticleId></ArticleIdList></Reference><Reference><Citation>Grad L.I., Yerbury J.J., Turner B.J., Guest W.C., Pokrishevsky E., O&#x2019;Neill M.A., Yanai A., Silverman J.M., Zeineddine R., Corcoran L., et al. Intercellular propagated misfolding of wild-type Cu/Zn superoxide dismutase occurs via exosome-dependent and -independent mechanisms. Proc. Natl. Acad. Sci. USA. 2014;111:3620&#x2013;3625. doi: 10.1073/pnas.1312245111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1312245111</ArticleId><ArticleId IdType="pmc">PMC3948312</ArticleId><ArticleId IdType="pubmed">24550511</ArticleId></ArticleIdList></Reference><Reference><Citation>Grad L.I., Guest W.C., Yanai A., Pokrishevsky E., O&#x2019;Neill M.A., Gibbs E., Semenchenko V., Yousefi M., Wishart D.S., Plotkin S.S., et al. Intermolecular transmission of superoxide dismutase 1 misfolding in living cells. Proc. Natl. Acad. Sci. USA. 2011;108:16398&#x2013;16403. doi: 10.1073/pnas.1102645108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1102645108</ArticleId><ArticleId IdType="pmc">PMC3182705</ArticleId><ArticleId IdType="pubmed">21930926</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeineddine R., Pundavela J.F., Corcoran L., Stewart E.M., Do-Ha D., Bax M., Guillemin G., Vine K.L., Hatters D.M., Ecroyd H., et al. SOD1 protein aggregates stimulate macropinocytosis in neurons to facilitate their propagation. Mol. Neurodegener. 2015;10:57. doi: 10.1186/s13024-015-0053-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-015-0053-4</ArticleId><ArticleId IdType="pmc">PMC4628302</ArticleId><ArticleId IdType="pubmed">26520394</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayers J.I., Fromholt S., Koch M., DeBosier A., McMahon B., Xu G., Borchelt D.R. Experimental transmissibility of mutant SOD1 motor neuron disease. Acta Neuropathol. 2014;128:791&#x2013;803. doi: 10.1007/s00401-014-1342-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-014-1342-7</ArticleId><ArticleId IdType="pubmed">25262000</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayers J.I., Diamond J., Sari A., Fromholt S., Galaleldeen A., Ostrow L.W., Glass J.D., Hart P.J., Borchelt D.R. Distinct conformers of transmissible misfolded SOD1 distinguish human SOD1-FALS from other forms of familial and sporadic ALS. Acta Neuropathol. 2016;132:827&#x2013;840. doi: 10.1007/s00401-016-1623-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-016-1623-4</ArticleId><ArticleId IdType="pmc">PMC5107152</ArticleId><ArticleId IdType="pubmed">27704280</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayers J.I., Fromholt S.E., O&#x2019;Neal V.M., Diamond J.H., Borchelt D.R. Prion-like propagation of mutant SOD1 misfolding and motor neuron disease spread along neuroanatomical pathways. Acta Neuropathol. 2016;131:103&#x2013;114. doi: 10.1007/s00401-015-1514-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1514-0</ArticleId><ArticleId IdType="pmc">PMC4699876</ArticleId><ArticleId IdType="pubmed">26650262</ArticleId></ArticleIdList></Reference><Reference><Citation>Bidhendi E.E., Bergh J., Zetterstr&#xf6;m P., Andersen P.M., Marklund S.L., Br&#xe4;nnstr&#xf6;m T. Two superoxide dismutase prion strains transmit amyotrophic lateral sclerosis-like disease. J. Clin. Investig. 2016;126:2249&#x2013;2253. doi: 10.1172/JCI84360.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI84360</ArticleId><ArticleId IdType="pmc">PMC4887173</ArticleId><ArticleId IdType="pubmed">27140399</ArticleId></ArticleIdList></Reference><Reference><Citation>Ekhtiari Bidhendi E., Bergh J., Zetterstr&#xf6;m P., Forsberg K., Pakkenberg B., Andersen P.M., Marklund S.L., Br&#xe4;nnstr&#xf6;m T. Mutant superoxide dismutase aggregates from human spinal cord transmit amyotrophic lateral sclerosis. Acta Neuropathol. 2018;136:939&#x2013;953. doi: 10.1007/s00401-018-1915-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1915-y</ArticleId><ArticleId IdType="pmc">PMC6280858</ArticleId><ArticleId IdType="pubmed">30284034</ArticleId></ArticleIdList></Reference><Reference><Citation>Tokuda E., Nomura T., Ohara S., Watanabe S., Yamanaka K., Morisaki Y., Misawa H., Furukawa Y. A copper-deficient form of mutant Cu/Zn-superoxide dismutase as an early pathological species in amyotrophic lateral sclerosis. Biochim. Biophys. Acta Mol. Basis Dis. 2018;1864:2119&#x2013;2130. doi: 10.1016/j.bbadis.2018.03.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2018.03.015</ArticleId><ArticleId IdType="pubmed">29551730</ArticleId></ArticleIdList></Reference><Reference><Citation>Tokuda E., Takei Y.I., Ohara S., Fujiwara N., Hozumi I., Furukawa Y. Wild-type Cu/Zn-superoxide dismutase is misfolded in cerebrospinal fluid of sporadic amyotrophic lateral sclerosis. Mol. Neurodegener. 2019;14:42. doi: 10.1186/s13024-019-0341-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-019-0341-5</ArticleId><ArticleId IdType="pmc">PMC6862823</ArticleId><ArticleId IdType="pubmed">31744522</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng Kee Kwong K.C., Mehta A.R., Nedergaard M., Chandran S. Defining novel functions for cerebrospinal fluid in ALS pathophysiology. Acta Neuropathol. Commun. 2020;8:140. doi: 10.1186/s40478-020-01018-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-020-01018-0</ArticleId><ArticleId IdType="pmc">PMC7439665</ArticleId><ArticleId IdType="pubmed">32819425</ArticleId></ArticleIdList></Reference><Reference><Citation>Urushitani M., Sik A., Sakurai T., Nukina N., Takahashi R., Julien J.P. Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis. Nat. Neurosci. 2006;9:108&#x2013;118. doi: 10.1038/nn1603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1603</ArticleId><ArticleId IdType="pubmed">16369483</ArticleId></ArticleIdList></Reference><Reference><Citation>Jonsson P.A., Graffmo K.S., Andersen P.M., Br&#xe4;nnstr&#xf6;m T., Lindberg M., Oliveberg M., Marklund S.L. Disulphide-reduced superoxide dismutase-1 in CNS of transgenic amyotrophic lateral sclerosis models. Brain. 2006;129:451&#x2013;464. doi: 10.1093/brain/awh704.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awh704</ArticleId><ArticleId IdType="pubmed">16330499</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayward L.J., Rodriguez J.A., Kim J.W., Tiwari A., Goto J.J., Cabelli D.E., Valentine J.S., Brown R.H., Jr. Decreased metallation and activity in subsets of mutant superoxide dismutases associated with familial amyotrophic lateral sclerosis. J. Biol. Chem. 2002;277:15923&#x2013;15931. doi: 10.1074/jbc.M112087200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M112087200</ArticleId><ArticleId IdType="pubmed">11854284</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright G.S.A., Antonyuk S.V., Hasnain S.S. The biophysics of superoxide dismutase-1 and amyotrophic lateral sclerosis. Q. Rev. Biophys. 2019;52:e12. doi: 10.1017/S003358351900012X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S003358351900012X</ArticleId><ArticleId IdType="pubmed">31760962</ArticleId></ArticleIdList></Reference><Reference><Citation>Borchelt D.R., Lee M.K., Slunt H.S., Guarnieri M., Xu Z.S., Wong P.C., Brown R.H., Jr., Price D.L., Sisodia S.S., Cleveland D.W. Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity. Proc. Natl. Acad. Sci. USA. 1994;91:8292&#x2013;8296. doi: 10.1073/pnas.91.17.8292.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.91.17.8292</ArticleId><ArticleId IdType="pmc">PMC44592</ArticleId><ArticleId IdType="pubmed">8058797</ArticleId></ArticleIdList></Reference><Reference><Citation>Marklund S.L., Andersen P.M., Forsgren L., Nilsson P., Ohlsson P.I., Wikander G., Oberg A. Normal binding and reactivity of copper in mutant superoxide dismutase isolated from amyotrophic lateral sclerosis patients. J. Neurochem. 1997;69:675&#x2013;681. doi: 10.1046/j.1471-4159.1997.69020675.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.1997.69020675.x</ArticleId><ArticleId IdType="pubmed">9231727</ArticleId></ArticleIdList></Reference><Reference><Citation>Rakhit R., Robertson J., Vande Velde C., Horne P., Ruth D.M., Griffin J., Cleveland D.W., Cashman N.R., Chakrabartty A. An immunological epitope selective for pathological monomer-misfolded SOD1 in ALS. Nat. Med. 2007;13:754&#x2013;759. doi: 10.1038/nm1559.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1559</ArticleId><ArticleId IdType="pubmed">17486090</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayers J.I., Xu G., Pletnikova O., Troncoso J.C., Hart P.J., Borchelt D.R. Conformational specificity of the C4F6 SOD1 antibody; low frequency of reactivity in sporadic ALS cases. Acta Neuropathol. Commun. 2014;2:55. doi: 10.1186/2051-5960-2-55.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2051-5960-2-55</ArticleId><ArticleId IdType="pmc">PMC4035506</ArticleId><ArticleId IdType="pubmed">24887207</ArticleId></ArticleIdList></Reference><Reference><Citation>Rotunno M.S., Auclair J.R., Maniatis S., Shaffer S.A., Agar J., Bosco D.A. Identification of a misfolded region in superoxide dismutase 1 that is exposed in amyotrophic lateral sclerosis. J. Biol. Chem. 2014;289:28527&#x2013;28538. doi: 10.1074/jbc.M114.581801.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M114.581801</ArticleId><ArticleId IdType="pmc">PMC4192504</ArticleId><ArticleId IdType="pubmed">25164820</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindberg M.J., Tibell L., Oliveberg M. Common denominator of Cu/Zn superoxide dismutase mutants associated with amyotrophic lateral sclerosis: Decreased stability of the apo state. Proc. Natl. Acad. Sci. USA. 2002;99:16607&#x2013;16612. doi: 10.1073/pnas.262527099.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.262527099</ArticleId><ArticleId IdType="pmc">PMC139191</ArticleId><ArticleId IdType="pubmed">12482932</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner B.J., Atkin J.D., Farg M.A., Zang D.W., Rembach A., Lopes E.C., Patch J.D., Hill A.F., Cheema S.S. Impaired extracellular secretion of mutant superoxide dismutase 1 associates with neurotoxicity in familial amyotrophic lateral sclerosis. J. Neurosci. 2005;25:108&#x2013;117. doi: 10.1523/JNEUROSCI.4253-04.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4253-04.2005</ArticleId><ArticleId IdType="pmc">PMC6725218</ArticleId><ArticleId IdType="pubmed">15634772</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiwari A., Hayward L.J. Familial amyotrophic lateral sclerosis mutants of copper/zinc superoxide dismutase are susceptible to disulfide reduction. J. Biol. Chem. 2003;278:5984&#x2013;5992. doi: 10.1074/jbc.M210419200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M210419200</ArticleId><ArticleId IdType="pubmed">12458194</ArticleId></ArticleIdList></Reference><Reference><Citation>Furukawa Y., O&#x2019;Halloran T.V. Amyotrophic lateral sclerosis mutations have the greatest destabilizing effect on the apo- and reduced form of SOD1, leading to unfolding and oxidative aggregation. J. Biol. Chem. 2005;280:17266&#x2013;17274. doi: 10.1074/jbc.M500482200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M500482200</ArticleId><ArticleId IdType="pubmed">15691826</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Domenico F., Tramutola A., Butterfield D.A. Role of 4-hydroxy-2-nonenal (HNE) in the pathogenesis of alzheimer disease and other selected age-related neurodegenerative disorders. Free Radic. Biol. Med. 2017;111:253&#x2013;261. doi: 10.1016/j.freeradbiomed.2016.10.490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2016.10.490</ArticleId><ArticleId IdType="pubmed">27789292</ArticleId></ArticleIdList></Reference><Reference><Citation>Rae T.D., Torres A.S., Pufahl R.A., O&#x2019;Halloran T.V. Mechanism of Cu,Zn-superoxide dismutase activation by the human metallochaperone hCCS. J. Biol. Chem. 2001;276:5166&#x2013;5176. doi: 10.1074/jbc.M008005200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M008005200</ArticleId><ArticleId IdType="pubmed">11018045</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H.T., Jiao M., Chen J., Liang Y. Roles of zinc and copper in modulating the oxidative refolding of bovine copper, zinc superoxide dismutase. Acta Biochim. Biophys. Sin. 2010;42:183&#x2013;194. doi: 10.1093/abbs/gmq005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/abbs/gmq005</ArticleId><ArticleId IdType="pubmed">20213043</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedersen W.A., Fu W., Keller J.N., Markesbery W.R., Appel S., Smith R.G., Kasarskis E., Mattson M.P. Protein modification by the lipid peroxidation product 4-hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis patients. Ann. Neurol. 1998;44:819&#x2013;824. doi: 10.1002/ana.410440518.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410440518</ArticleId><ArticleId IdType="pubmed">9818940</ArticleId></ArticleIdList></Reference><Reference><Citation>Tohgi H., Abe T., Yamazaki K., Murata T., Ishizaki E., Isobe C. Remarkable increase in cerebrospinal fluid 3-nitrotyrosine in patients with sporadic amyotrophic lateral sclerosis. Ann. Neurol. 1999;46:129&#x2013;131. doi: 10.1002/1531-8249(199907)46:1&lt;129::AID-ANA21&gt;3.0.CO;2-Y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1531-8249(199907)46:1&lt;129::AID-ANA21&gt;3.0.CO;2-Y</ArticleId><ArticleId IdType="pubmed">10401792</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu W.C., Liang J.Z., Li C., He Z.X., Yuan H.Y., Huang B.Y., Liu X.L., Tang B., Pang D.W., Du H.N., et al. Pathological hydrogen peroxide triggers the fibrillization of wild-type SOD1 via sulfenic acid modification of Cys-111. Cell Death Dis. 2018;9:67. doi: 10.1038/s41419-017-0106-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-017-0106-4</ArticleId><ArticleId IdType="pmc">PMC5833406</ArticleId><ArticleId IdType="pubmed">29358575</ArticleId></ArticleIdList></Reference><Reference><Citation>Anzai I., Tokuda E., Handa S., Misawa H., Akiyama S., Furukawa Y. Oxidative misfolding of Cu/Zn-superoxide dismutase triggered by non-canonical intramolecular disulfide formation. Free Radic. Biol. Med. 2020;147:187&#x2013;199. doi: 10.1016/j.freeradbiomed.2019.12.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2019.12.017</ArticleId><ArticleId IdType="pubmed">31863908</ArticleId></ArticleIdList></Reference><Reference><Citation>Chattopadhyay M., Nwadibia E., Strong C.D., Gralla E.B., Valentine J.S., Whitelegge J.P. The Disulfide Bond, but Not Zinc or Dimerization, Controls Initiation and Seeded Growth in Amyotrophic Lateral Sclerosis-linked Cu,Zn Superoxide Dismutase (SOD1) Fibrillation. J. Biol. Chem. 2015;290:30624&#x2013;30636. doi: 10.1074/jbc.M115.666503.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M115.666503</ArticleId><ArticleId IdType="pmc">PMC4683282</ArticleId><ArticleId IdType="pubmed">26511321</ArticleId></ArticleIdList></Reference><Reference><Citation>Jonsson P.A., Ernhill K., Andersen P.M., Bergemalm D., Br&#xe4;nnstr&#xf6;m T., Gredal O., Nilsson P., Marklund S.L. Minute quantities of misfolded mutant superoxide dismutase-1 cause amyotrophic lateral sclerosis. Brain. 2004;127:73&#x2013;88. doi: 10.1093/brain/awh005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awh005</ArticleId><ArticleId IdType="pubmed">14534160</ArticleId></ArticleIdList></Reference><Reference><Citation>Sundaramoorthy V., Walker A.K., Yerbury J., Soo K.Y., Farg M.A., Hoang V., Zeineddine R., Spencer D., Atkin J.D. Extracellular wildtype and mutant SOD1 induces ER-Golgi pathology characteristic of amyotrophic lateral sclerosis in neuronal cells. Cell Mol. Life Sci. 2013;70:4181&#x2013;4195. doi: 10.1007/s00018-013-1385-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-013-1385-2</ArticleId><ArticleId IdType="pubmed">23765103</ArticleId></ArticleIdList></Reference><Reference><Citation>Benkler C., O&#x2019;Neil A.L., Slepian S., Qian F., Weinreb P.H., Rubin L.L. Aggregated SOD1 causes selective death of cultured human motor neurons. Sci. Rep. 2018;8:16393. doi: 10.1038/s41598-018-34759-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-34759-z</ArticleId><ArticleId IdType="pmc">PMC6219543</ArticleId><ArticleId IdType="pubmed">30401824</ArticleId></ArticleIdList></Reference><Reference><Citation>Hwang C., Sinskey A.J., Lodish H.F. Oxidized redox state of glutathione in the endoplasmic reticulum. Science. 1992;257:1496&#x2013;1502. doi: 10.1126/science.1523409.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1523409</ArticleId><ArticleId IdType="pubmed">1523409</ArticleId></ArticleIdList></Reference><Reference><Citation>Furukawa Y., Kaneko K., Yamanaka K., O&#x2019;Halloran T.V., Nukina N. Complete loss of post-translational modifications triggers fibrillar aggregation of SOD1 in the familial form of amyotrophic lateral sclerosis. J. Biol. Chem. 2008;283:24167&#x2013;24176. doi: 10.1074/jbc.M802083200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M802083200</ArticleId><ArticleId IdType="pmc">PMC3259764</ArticleId><ArticleId IdType="pubmed">18552350</ArticleId></ArticleIdList></Reference><Reference><Citation>Chattopadhyay M., Durazo A., Sohn S.H., Strong C.D., Gralla E.B., Whitelegge J.P., Valentine J.S. Initiation and elongation in fibrillation of ALS-linked superoxide dismutase. Proc. Natl. Acad. Sci. USA. 2008;105:18663&#x2013;18668. doi: 10.1073/pnas.0807058105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0807058105</ArticleId><ArticleId IdType="pmc">PMC2585484</ArticleId><ArticleId IdType="pubmed">19022905</ArticleId></ArticleIdList></Reference><Reference><Citation>Urushitani M., Ezzi S.A., Julien J.P. Therapeutic effects of immunization with mutant superoxide dismutase in mice models of amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA. 2007;104:2495&#x2013;2500. doi: 10.1073/pnas.0606201104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0606201104</ArticleId><ArticleId IdType="pmc">PMC1790867</ArticleId><ArticleId IdType="pubmed">17277077</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansson A.S., Vestling M., Zetterstr&#xf6;m P., Lang L., Leinartait&#x117; L., Karlstr&#xf6;m M., Danielsson J., Marklund S.L., Oliveberg M. Cytotoxicity of superoxide dismutase 1 in cultured cells is linked to Zn2+ chelation. PLoS ONE. 2012;7:e36104. doi: 10.1371/journal.pone.0036104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0036104</ArticleId><ArticleId IdType="pmc">PMC3338499</ArticleId><ArticleId IdType="pubmed">22558346</ArticleId></ArticleIdList></Reference><Reference><Citation>Homma K., Fujisawa T., Tsuburaya N., Yamaguchi N., Kadowaki H., Takeda K., Nishitoh H., Matsuzawa A., Naguro I., Ichijo H. SOD1 as a molecular switch for initiating the homeostatic ER stress response under zinc deficiency. Mol. Cell. 2013;52:75&#x2013;86. doi: 10.1016/j.molcel.2013.08.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2013.08.038</ArticleId><ArticleId IdType="pubmed">24076220</ArticleId></ArticleIdList></Reference><Reference><Citation>Sekhar A., Rumfeldt J.A., Broom H.R., Doyle C.M., Bouvignies G., Meiering E.M., Kay L.E. Thermal fluctuations of immature SOD1 lead to separate folding and misfolding pathways. Elife. 2015;4:e07296. doi: 10.7554/eLife.07296.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.07296</ArticleId><ArticleId IdType="pmc">PMC4475725</ArticleId><ArticleId IdType="pubmed">26099300</ArticleId></ArticleIdList></Reference><Reference><Citation>Wada K., Fujibayashi Y., Tajima N., Yokoyama A. Cu-ATSM, an intracellular-accessible superoxide dismutase (SOD)-like copper complex: Evaluation in an ischemia-reperfusion injury model. Biol. Pharm. Bull. 1994;17:701&#x2013;704. doi: 10.1248/bpb.17.701.</Citation><ArticleIdList><ArticleId IdType="doi">10.1248/bpb.17.701</ArticleId><ArticleId IdType="pubmed">7920437</ArticleId></ArticleIdList></Reference><Reference><Citation>Farrawell N.E., Yerbury M.R., Plotkin S.S., McAlary L., Yerbury J.J. CuATSM Protects Against the In Vitro Cytotoxicity of Wild-Type-Like Copper-Zinc Superoxide Dismutase Mutants but not Mutants That Disrupt Metal Binding. ACS Chem. Neurosci. 2019;10:1555&#x2013;1564. doi: 10.1021/acschemneuro.8b00527.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.8b00527</ArticleId><ArticleId IdType="pubmed">30462490</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts B.R., Lim N.K., McAllum E.J., Donnelly P.S., Hare D.J., Doble P.A., Turner B.J., Price K.A., Lim S.C., Paterson B.M., et al. Oral treatment with Cu(II)(atsm) increases mutant SOD1 in vivo but protects motor neurons and improves the phenotype of a transgenic mouse model of amyotrophic lateral sclerosis. J. Neurosci. 2014;34:8021&#x2013;8031. doi: 10.1523/JNEUROSCI.4196-13.2014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4196-13.2014</ArticleId><ArticleId IdType="pmc">PMC6608261</ArticleId><ArticleId IdType="pubmed">24899723</ArticleId></ArticleIdList></Reference><Reference><Citation>Soon C.P., Donnelly P.S., Turner B.J., Hung L.W., Crouch P.J., Sherratt N.A., Tan J.L., Lim N.K., Lam L., Bica L., et al. Diacetylbis(N(4)-methylthiosemicarbazonato) copper(II) (CuII(atsm)) protects against peroxynitrite-induced nitrosative damage and prolongs survival in amyotrophic lateral sclerosis mouse model. J. Biol. Chem. 2011;286:44035&#x2013;44044. doi: 10.1074/jbc.M111.274407.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.274407</ArticleId><ArticleId IdType="pmc">PMC3243559</ArticleId><ArticleId IdType="pubmed">22033929</ArticleId></ArticleIdList></Reference><Reference><Citation>McAllum E.J., Lim N.K., Hickey J.L., Paterson B.M., Donnelly P.S., Li Q.X., Liddell J.R., Barnham K.J., White A.R., Crouch P.J. Therapeutic effects of CuII(atsm) in the SOD1-G37R mouse model of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Frontotemporal Degener. 2013;14:586&#x2013;590. doi: 10.3109/21678421.2013.824000.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.824000</ArticleId><ArticleId IdType="pubmed">23952668</ArticleId></ArticleIdList></Reference><Reference><Citation>Cashman N.R., Durham H.D., Blusztajn J.K., Oda K., Tabira T., Shaw I.T., Dahrouge S., Antel J.P. Neuroblastoma x spinal cord (NSC) hybrid cell lines resemble developing motor neurons. Dev. Dyn. 1992;194:209&#x2013;221. doi: 10.1002/aja.1001940306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/aja.1001940306</ArticleId><ArticleId IdType="pubmed">1467557</ArticleId></ArticleIdList></Reference><Reference><Citation>Furukawa Y., Fu R., Deng H.X., Siddique T., O&#x2019;Halloran T.V. Disulfide cross-linked protein represents a significant fraction of ALS-associated Cu, Zn-superoxide dismutase aggregates in spinal cords of model mice. Proc. Natl. Acad. Sci. USA. 2006;103:7148&#x2013;7153. doi: 10.1073/pnas.0602048103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0602048103</ArticleId><ArticleId IdType="pmc">PMC1447524</ArticleId><ArticleId IdType="pubmed">16636274</ArticleId></ArticleIdList></Reference><Reference><Citation>Tokuda E., Anzai I., Nomura T., Toichi K., Watanabe M., Ohara S., Watanabe S., Yamanaka K., Morisaki Y., Misawa H., et al. Immunochemical characterization on pathological oligomers of mutant Cu/Zn-superoxide dismutase in amyotrophic lateral sclerosis. Mol. Neurodegener. 2017;12:2. doi: 10.1186/s13024-016-0145-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-016-0145-9</ArticleId><ArticleId IdType="pmc">PMC5216565</ArticleId><ArticleId IdType="pubmed">28057013</ArticleId></ArticleIdList></Reference><Reference><Citation>Rigo A., Viglino P., Rotilio G. Kinetic study of O-2 DISMUTATION BY BOVINE SUPEROXIDE DISMUTASE. Evidence for saturation of the catalytic sites by O-2. Biochem. Biophys. Res. Commun. 1975;63:1013&#x2013;1018. doi: 10.1016/0006-291X(75)90670-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0006-291X(75)90670-1</ArticleId><ArticleId IdType="pubmed">236750</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>